N/A N=80 Conservative Treatment of Patients With Temporomandibular Disorders
Temporomandibular Disorders
Primary: Patient-Rated TMD Pain, an 11 Point Numerical Rating Scale (NRS) — 0.9; 1.4; 1.6; 0.7 units on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=191 Managing Temporomandibular Disorder (TMD) Symptoms
Temporomandibular Joint Disorders
Primary: Characteristic Pain Intensity (Characteristic Intensity of Facial Pain) — 3.1; 2.9; 3.6 units on a scale — p=0.19
N/A N=24 Duloxetine for Treatment of Painful Temporomandibular Joint Disorder
Temporomandibular Joint Disorders
Primary: Spontaneous Pain as Measured by Visual Analog Scale at Baseline and at End of 6 Weeks. — 42.9; 51.4; 30.4; 44 units on a scale
Phase 2 N=79 Traditional Chinese Medicine (TCM) for Temporomandibular Dysfunction (TMD): A Whole Systems Multi-site Trial
Temporomandibular Dysfunction
Primary: Characteristic Facial Pain Score — 6.52; 6.55; 5.11; 5.47 units on a scale — p=0.020
Phase 3 N=58 Biofeedback-Based Cognitive Behavioral Treatment for Temporomandibular Disorders
Temporomandibular Disorders
Primary: Pain Intensity (German Pain Questionnaire; Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD)) — 5.40; 5.53; 3.90; 3.89 units on a scale
N/A N=24 Motor Cortex as a Research & Therapeutic Target in TMD
Temporomandibular Joint Disorders
Primary: Number of Participants With Pain Relief as Measured by Visual Analog Scale (VAS) Decrease of 50% or Greater From Baseline — 4; 9 participants
Phase 2 N=152 Treatment Outcomes for Temporomandibular Disorders (TMD) Via the Clayton Intra-aural Device (CID) Clinical Trial
Temporomandibular Disorders
Primary: Change From Baseline In Craniomandibular Index (CMI) Scores At 3 Months (In A Scale) — .23; .20 Units on a scale — p=<0.0096
N/A N=80 Tailored Self-Management of Temporomandibular Disorders (TMD) Using Health Information Technology
Temporomandibular Joint Dysfunction Syndrome
Primary: Assessing Graded Chronic Pain Severity Evaluation Feasibility of the PACT Program — -12; -19 units on a scale
Phase 2 N=21 Occlusal Adjustment as Treatment for Chronic Orofacial Pain
Temporomandibular Joint Disorders · Orofacial Pain
Primary: Visual Analogic Scale for Pain Intensity (0-10) — 6.52; 4.8; .81; 2.05 units on a scale
N/A N=74 The Effectiveness of a Physiotherapy Technique in Patients With Chronic Myofascial Temporomandibular Disorder
Myofascial Pain Syndrome · Temporomandibular Disorder
Primary: Changes of Perceived Pain Between Three Time Points (Baseline, Post-treatment, and 3 Months Later) and Between Groups (Sham Simulation and Pressure Release Technique)…
Phase 4 N=200 Efficacy of Naproxen-codeine, Naproxen+Dexamethasone, and Naproxen on Myofascial Pain
Temporomandibular Disorder
Primary: Pain Evaluation — 6.38; 6.93; 5.76; 5.49 score on a scale
Phase 2 N=140 Comparison of Psychological and Pharmacological Treatments for Pain Due to Temporomandibular Joint Disorder (TMD)
Temporomandibular Joint Disorders
Primary: Average Pain — 4.7; 4.4; 4.5; 5.0 units on a scale — p=<.05
Phase 2 N=30 Safety and Efficacy of Erenumab-aooe in Patients With Temporomandibular Disorder
Temporomandibular Disorder
Primary: Brief Pain Inventory (BPI) Pain Severity at 20 Weeks — 1.72; 1.42 score on a scale — p=0.567
Phase 2 N=51 Effectiveness of Photobiomodulation and Manual Therapy Alone or Combined in TMD Patients
Temporomandibular Disorder
Primary: Change From Baseline in Visual Analogic Scale (VAS) for Pain — 4.1; 4.4; 5.2; 3.3 millimeters — p=<0.001
N/A N=28 Immediate Effect of Ultrasound Therapy on Bilateral Masseter Myalgia: Randomized Single Blinded Investigational Trial
Temporomandibular Joint Dysfunction Syndrome
Primary: Self Report of Pain — -.86; -2.0; -1.4; -1.3 Scores on pain intensity scale — p=0.17
N/A N=171 Assessing a New Jaw Support Device During Third Molar Extractions
Impacted Third Molar Tooth · Temporomandibular Disorder
Primary: Occurrence of Pain at Follow-up With Wide Opening, or Pain in the Temple, Jaw Joint or Jaw Muscles. — 26; 32; 54; 53 Participants
Phase 2 N=200 Study of Orofacial Pain and PropRANOlol
Temporomandibular Disorders
Primary: Change in the Weekly Mean Pain Index After 9 Weeks of Treatment — -13.9; -12.1 units on a scale — p=0.414
N/A N=14 Study of a New Technique to Improve the Symptoms of Orofacial Discomfort in Patients With Peripheral Facial Paralysis
Peripheral Nerve Facial Nerve Paralysis · Facial Nerve Diseases · Orofacial Pain
Primary: The Visual Analog Scale for Pain Was Used to Grade Discomfort in Chewing After the Installation of Facial Paralysis. Level Zero is the Lack of Discomfort and 10 is the…
N/A N=9 Transcranial Magnetic Stimulation for Facial Pain
Trigeminal Nerve Injuries · Post-herpetic Neuralgia · Facial Pain
Primary: Visual Analogue Scale (VAS) — 5.4 score on a scale
N/A N=20 Intra-articular Injection in Arthroscopic Management of Temporomandibular Diseases
Temporomandibular Joint Disorders
Primary: Maximum Interincisal Opening (MIO) Measurements — 23.1; 27.9; 33.8; 35.6 Millimeter
Phase 4 N=102 A Double Blind Study Comparing Hyaluronic Acid, Corticosteroid and Placebo During Arthrocentesis for Temporomandibular Joint (TMJ) Dysfunction
Temporomandibular Joint Dysfunction · Pain · Arthrocentesis
Primary: Change in Pain Between Baseline and Month 1 Scores — -1.1; -1.7; -2.6; -2.0 units on a scale
Phase 3 N=75 Botulinum Toxin Versus Placebo Injections to Temporalis and Masseter Muscles
Pain, Head · Pain Syndrome · Temporomandibular Disorder
Primary: Change in Jaw Pain as Reported by Patient on Visual Analog Scale (VAS) — 58; 54; -19; -14 score on a scale — p=0.80
N/A N=21 TMD Online Program for Pain Management
TMD/Orofacial Pain
Primary: Treatment Feasibility — 18 Participants — p=.05
N/A N=55 Analgesic Ointment on Temporomandibular Joint and Masticatory Muscle Pain
Temporomandibular Disorders
Primary: The Efficacy in the Treatment of TMJ and Muscle Pain — 21.93; 40.81 units on a scale
Phase 2 N=24 Efficacy of Steroid Supplementation After TMJ Rinsing for Pain Management
Pain
Primary: Change From Pre-Treatment in TMJ Loading Pain Rating at 12 Weeks — -1; -2 units on a scale
N/A N=16 Eustachian Tube Dysfunction Assessment
Eustachian Tube Dysfunction
Primary: Latency Between mLVP and mTVP Signals — 127.26 Time in milliseconds
N/A N=20 rTMS in Spasmodic Dysphonia
Spasmodic Dysphonia · Laryngeal Dystonia
Primary: Adverse Response to rTMS — 0; 0 Participants
N/A N=30 Efficacy of Photobiomodulation Therapy Using 980nm Versus 635nm Diode Lasers for Treatment of Myofascial Pain
Myofascial Pain Syndrome
Primary: Pain Intensity Reduction — 7.6; 7.8; 3.2; 2.5 "units on scale — p=0.05
Phase 2 N=60 The Effect of Opioid-Free Anesthesia in TMJ Surgery
Temporomandibular Joint Disorders
Primary: Pain Score — 4.9; 4.4 units on a scale
N/A N=30 SinuSonic for ETD and Facial Pain: Acoustic Vibration + Oscillating Expiratory Pressure
Eustachian Tube Dysfunction · Facial Pain
Primary: Eustachian Tube Dysfunction (ETD) Symptom Visual Analog Scale (VAS) - Total Score — 59.6 score on a scale